122 related articles for article (PubMed ID: 1310951)
1. B-cell lymphoproliferative disorders in solid-organ transplant patients: detection of Epstein-Barr virus by in situ hybridization.
Berg LC; Copenhaver CM; Morrison VA; Gruber SA; Dunn DL; Gajl-Peczalska K; Strickler JG
Hum Pathol; 1992 Feb; 23(2):159-63. PubMed ID: 1310951
[TBL] [Abstract][Full Text] [Related]
2. In situ hybridization for Epstein-Barr virus NotI repeats in posttransplant lymphoproliferative disorder.
Montone KT; Friedman H; Hodinka RL; Hicks DG; Kant JA; Tomaszewski JE
Mod Pathol; 1992 May; 5(3):292-302. PubMed ID: 1323104
[TBL] [Abstract][Full Text] [Related]
3. B-cell lymphoproliferative disorders after bone marrow transplant. An analysis of ten cases with emphasis on Epstein-Barr virus detection by in situ hybridization.
d'Amore ES; Manivel JC; Gajl-Peczalska KJ; Litz CE; Copenhaver CM; Shapiro RS; Strickler JG
Cancer; 1991 Sep; 68(6):1285-95. PubMed ID: 1651803
[TBL] [Abstract][Full Text] [Related]
4. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation.
Rea D; Fourcade C; Leblond V; Rowe M; Joab I; Edelman L; Bitker MO; Gandjbakhch I; Suberbielle C; Farcet JP
Transplantation; 1994 Aug; 58(3):317-24. PubMed ID: 8053055
[TBL] [Abstract][Full Text] [Related]
5. Immunoregulatory abnormalities in patients with Epstein-Barr virus-associated B cell lymphoproliferative disorders.
Mathur A; Kamat DM; Filipovich AH; Steinbuch M; Shapiro RS
Transplantation; 1994 Apr; 57(7):1042-5. PubMed ID: 8165700
[TBL] [Abstract][Full Text] [Related]
6. Association between Epstein-Barr virus seroconversion and immunohistochemical changes in tonsils of pediatric solid organ transplant recipients.
Shapiro NL; Tang CG; Bhattacharyya N
Laryngoscope; 2011 Aug; 121(8):1718-25. PubMed ID: 21792960
[TBL] [Abstract][Full Text] [Related]
7. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus.
Hanto DW; Frizzera G; Purtilo DT; Sakamoto K; Sullivan JL; Saemundsen AK; Klein G; Simmons RL; Najarian JS
Cancer Res; 1981 Nov; 41(11 Pt 1):4253-61. PubMed ID: 6272971
[TBL] [Abstract][Full Text] [Related]
8. Identification of Epstein-Barr virus lytic activity in post-transplantation lymphoproliferative disease.
Montone KT; Hodinka RL; Salhany KE; Lavi E; Rostami A; Tomaszewski JE
Mod Pathol; 1996 Jun; 9(6):621-30. PubMed ID: 8782198
[TBL] [Abstract][Full Text] [Related]
9. Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease.
Savoie A; Perpête C; Carpentier L; Joncas J; Alfieri C
Blood; 1994 May; 83(9):2715-22. PubMed ID: 8167350
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus (EBV)-encoded RNA: automated in-situ hybridization (ISH) compared with manual ISH and immunohistochemistry for detection of EBV in pediatric lymphoproliferative disorders.
Fanaian NK; Cohen C; Waldrop S; Wang J; Shehata BM
Pediatr Dev Pathol; 2009; 12(3):195-9. PubMed ID: 18442302
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection.
Ho M; Miller G; Atchison RW; Breinig MK; Dummer JS; Andiman W; Starzl TE; Eastman R; Griffith BP; Hardesty RL
J Infect Dis; 1985 Nov; 152(5):876-86. PubMed ID: 2995512
[TBL] [Abstract][Full Text] [Related]
12. Serologic evidence of active Epstein-Barr virus infection in Epstein-Barr virus-associated lymphoproliferative disorders of children with acquired immunodeficiency syndrome.
Katz BZ; Berkman AB; Shapiro ED
J Pediatr; 1992 Feb; 120(2 Pt 1):228-32. PubMed ID: 1310507
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation.
Shapiro RS; McClain K; Frizzera G; Gajl-Peczalska KJ; Kersey JH; Blazar BR; Arthur DC; Patton DF; Greenberg JS; Burke B
Blood; 1988 May; 71(5):1234-43. PubMed ID: 2833957
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis and Epstein-Barr virus in the tonsils of transplant recipients and healthy controls.
Mowry SE; Strocker AM; Chan J; Takehana C; Kalantar N; Bhuta S; Shapiro NL
Arch Otolaryngol Head Neck Surg; 2008 Sep; 134(9):936-9. PubMed ID: 18794437
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus latent membrane protein-1 oncogene deletion in post-transplantation lymphoproliferative disorders.
Scheinfeld AG; Nador RG; Cesarman E; Chadburn A; Knowles DM
Am J Pathol; 1997 Sep; 151(3):805-12. PubMed ID: 9284829
[TBL] [Abstract][Full Text] [Related]
16. The impact of EBV hybridization in clinical and biological medicine.
Morinet F
Nouv Rev Fr Hematol (1978); 1989; 31(2):155-8. PubMed ID: 2549502
[TBL] [Abstract][Full Text] [Related]
17. Role of Epstein-Barr virus status and immunophenotypic studies in the evaluation of exfoliative cytology specimens from patients with post-transplant lymphoproliferative disorders.
Gibson SE; Picarsic J; Swerdlow SH; Pantanowitz L
Cancer Cytopathol; 2016 Jun; 124(6):425-35. PubMed ID: 26992116
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency.
Cohen JI
Medicine (Baltimore); 1991 Mar; 70(2):137-60. PubMed ID: 1848644
[TBL] [Abstract][Full Text] [Related]
19. Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases.
Katz BZ; Raab-Traub N; Miller G
J Infect Dis; 1989 Oct; 160(4):589-98. PubMed ID: 2551973
[TBL] [Abstract][Full Text] [Related]
20. Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity?
Leblond V; Davi F; Charlotte F; Dorent R; Bitker MO; Sutton L; Gandjbakhch I; Binet JL; Raphael M
J Clin Oncol; 1998 Jun; 16(6):2052-9. PubMed ID: 9626203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
